Finally, therapeutic benefits of PGZ-NE on clinical, histological, and immunological aspects of AD were strongly demonstrated in this study with reduction of skin lesions, improvement of the skin barrier function, and decreased infiltration of inflammatory cells as well as in the expression of pro-inflammatory cytokines including TNF-α, IL-6, and IL-17. This evidence concerns the gene IL17A and Alzheimer disease.